84. サルコイドーシス [臨床試験数:143,薬物数:221(DrugBank:79),標的遺伝子数:82,標的パスウェイ数:165

Searched query = "Sarcoidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
5 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04314193June 1, 202024/2/2020Effectiveness of Methotrexate Versus Prednisolone as First-line Therapy for Pulmonary SarcoidosisThe PREDMETH Trial: Effectiveness of Methotrexate Versus Prednisolone as First-line Therapy for Pulmonary Sarcoidosis - A Randomized Controlled TrialSarcoidosis, PulmonaryDrug: Methotrexate;Drug: PrednisoloneErasmus Medical CenterSt. Antonius Hospital;LongfondsRecruiting18 YearsN/AAll138Phase 4Netherlands
2EUCTR2019-004148-31-NL26/02/202015/11/2019The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlled trialThe PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlled trial - PREDMETH trial pulmonary sarcoidosis;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]Trade Name: Methotrexate
Product Name: methotrexate
INN or Proposed INN: methotrexate
Other descriptive name: METHOTREXATE
Trade Name: Prednison
Product Name: Prednison
INN or Proposed INN: prednisone
Other descriptive name: PREDNISONE
Erasmus Medisch Centrum Dept. of PulmonologyNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
132Phase 4Netherlands
3NCT03593759January 15, 201927/6/2018Cardiac Sarcoidosis Randomized TrialCardiac Sarcoidosis Multi-Center Randomized Controlled TrialCardiac Sarcoidosis;SarcoidosisDrug: Prednisone;Drug: MethotrexateOttawa Heart Institute Research CorporationCanadian Institutes of Health Research (CIHR)Recruiting18 YearsN/AAll194Phase 3United States;Canada;United Kingdom
4JPRN-UMIN0000229962016/10/0804/07/2016Optimal Medical Therapy Estimated by FDG PET/CT in Myocardial SarcoidosisOptimal Medical Therapy Estimated by FDG PET/CT in Myocardial Sarcoidosis - Optimal Medical Therapy in Myocardial Sarcoidosis Myocardial sarcoidosismediacl therapy with methotrexate
medical therapy with steroid
The Department of Cardiology, Nagoya University Graduate School of MedicineNULLRecruiting20years-old90years-oldMale and Female50Not selectedJapan
5NCT00918554September 20099/6/2009Efficacy Study of Methotrexate to Treat Sarcoid-associated UveitisCorticosteroid Sparing Effect of Methotrexate in Patients With Sarcoid- Associated Uveitis: A Double Blind, Randomized, Placebo Controlled-study -UVEXATESarcoid-associated Uveitis;Ocular Sarcoidosis;Macular EdemaDrug: Methotrexate;Drug: PlaceboAssistance Publique - Hôpitaux de ParisNULLTerminated18 YearsN/ABoth7Phase 4France